| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.32 | 0.06 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.11 | 0.07 |